1-(2-(4-((4aS,8aR)-4-(3,4-Bis(difluoromethoxy)phenyl)-1-oxo-4a,5,8,8a-tetrahydrophthalazin-2(1H)-yl)piperidin-1-yl)-2-oxoethyl)-4,4-dimethylpiperidine-2,6-dione

ID: ALA4530777

PubChem CID: 137700769

Max Phase: Preclinical

Molecular Formula: C30H34F4N4O6

Molecular Weight: 622.62

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC(=O)N(CC(=O)N2CCC(N3N=C(c4ccc(OC(F)F)c(OC(F)F)c4)[C@H]4CC=CC[C@H]4C3=O)CC2)C(=O)C1

Standard InChI:  InChI=1S/C30H34F4N4O6/c1-30(2)14-23(39)37(24(40)15-30)16-25(41)36-11-9-18(10-12-36)38-27(42)20-6-4-3-5-19(20)26(35-38)17-7-8-21(43-28(31)32)22(13-17)44-29(33)34/h3-4,7-8,13,18-20,28-29H,5-6,9-12,14-16H2,1-2H3/t19-,20+/m0/s1

Standard InChI Key:  WVAQTVIALKSAMT-VQTJNVASSA-N

Molfile:  

 
     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
   36.9016  -20.6898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0844  -20.6898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4930  -21.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5685  -17.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5673  -18.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2795  -18.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2777  -17.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9905  -17.4256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9912  -18.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7039  -18.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4121  -18.2450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4074  -17.4188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6983  -17.0154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7056  -19.4813    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6934  -16.1992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4006  -15.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3966  -14.9627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6821  -14.5571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9742  -14.9738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9817  -15.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1256  -18.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1244  -19.4728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8338  -19.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5465  -19.4707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.5452  -18.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8314  -18.2341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2583  -19.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9855  -16.6080    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   28.9855  -19.0637    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   33.2605  -20.6964    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.9650  -19.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6737  -19.8755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.6729  -20.6905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3777  -21.0971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0865  -19.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3773  -19.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3743  -18.6437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.9651  -21.0988    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1018  -14.5499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8120  -14.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5172  -14.5413    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.8169  -15.7714    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.6756  -13.7399    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.3801  -13.3258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0910  -13.7288    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.3737  -12.5086    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 10 14  2  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 13 15  1  0
 11 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
  8 28  1  1
  9 29  1  1
 27 30  2  0
 27 31  1  0
 31 32  1  0
 32 33  1  0
 32 36  1  0
 33 34  1  0
 34  2  1  0
  2 35  1  0
 35 36  1  0
 36 37  2  0
 33 38  2  0
 17 39  1  0
 39 40  1  0
 40 41  1  0
 40 42  1  0
 18 43  1  0
 43 44  1  0
 44 45  1  0
 44 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4530777

    ---

Associated Targets(Human)

PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDEB1 Class 1 phosphodiesterase PDEB1 (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 622.62Molecular Weight (Monoisotopic): 622.2414AlogP: 4.18#Rotatable Bonds: 8
Polar Surface Area: 108.82Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.39CX LogP: 3.13CX LogD: 3.13
Aromatic Rings: 1Heavy Atoms: 44QED Weighted: 0.24Np Likeness Score: -0.90

References

1. Salado IG, Singh AK, Moreno-Cinos C, Sakaine G, Siderius M, Van der Veken P, Matheeussen A, van der Meer T, Sadek P, Gul S, Maes L, Sterk GJ, Leurs R, Brown D, Augustyns K..  (2020)  Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds.,  63  (7): [PMID:32196340] [10.1021/acs.jmedchem.9b00985]

Source